A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis.
about
Anti-inflammatory preconditioning by agonists of adenosine A1 receptorRegulation of neutrophil function by adenosine.Adenosine receptors as therapeutic targetsAdenosine receptors: therapeutic aspects for inflammatory and immune diseases.A2A receptors in inflammation and injury: lessons learned from transgenic animalsGraft versus host disease: New insights into A2A receptor agonist therapyA2aR antagonists: Next generation checkpoint blockade for cancer immunotherapyGenetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient miceAdenosine receptors as drug targets--what are the challenges?Emerging therapeutic targets of sepsis-associated acute kidney injury.Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.Immunological alterations mediated by adenosine during host-microbial interactionsEffects of adenosine A₂A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice.Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology.Adenosine A(2A) receptors in early ischemic vascular injury after subarachnoid hemorrhage. Laboratory investigation.Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosisResolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction.Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils.An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis modelsAdenosine and the auditory system.Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation.Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.CD39 improves survival in microbial sepsis by attenuating systemic inflammationExtracellular adenosine mediates a systemic metabolic switch during immune responseSystematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilitiesTargeting iNKT cells for the treatment of sickle cell disease.Dipyridamole augments the antiinflammatory response during human endotoxemiaTaming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control.(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis.Adenosine receptors in the response to sepsis: what do receptor-specific knockouts tell us?Purinergic Signaling and the Immune Response in Sepsis: A ReviewThe adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation.The adenosine A₂A receptor - myocardial protectant and coronary target in endotoxemia.Adenosine receptor antagonists effect on plasma-enhanced killing.Regulation of leukocyte function by adenosine receptors.Danger signal adenosine via adenosine 2a receptor stimulates growth of Porphyromonas gingivalis in primary gingival epithelial cells.Disease tolerance and immunity in host protection against infection.Adenosine regulates thrombomodulin and endothelial protein C receptor expression in folliculostellate cells of the pituitary gland.
P2860
Q21144315-9FC6DD97-2457-4F68-8F17-5EB8C61754D3Q24620317-CC3F2455-CD18-41AE-8E61-A060C2C2FCFCQ24632095-96CEC53B-AC4B-4927-AFDC-1E93CCDBE1CBQ24651475-00E2343E-AD53-4964-8C29-0EEC6CF4F8D5Q24652486-9B51E487-7CC8-4B2A-A8F8-DD87493FBAF0Q28080809-E81AEDAC-B076-4DCB-9714-63CD29EE99B4Q28087576-BC5E2A66-71C3-4068-B028-88DECD2A0B86Q28512453-6C722BD2-5AE4-4DCD-B068-142F77929A39Q29346491-9F07590F-0D93-4D0E-B6A7-B9331A1806A3Q30300333-76AA9A9E-6C9F-4CC6-8926-6D06A6C57B75Q30423298-DE86E8CC-0347-4458-B8CA-7A9401D4A9CCQ30426800-E2853FE6-2705-4890-AA5D-185F189D48D2Q30427422-0BEBD2B1-C44F-4977-9682-9B1A437E27BEQ30433245-E8087530-13B0-43A1-BCC8-8D15EF11260AQ30434574-76F4ED08-7DDF-4D60-A8CE-CA1B9D0FE808Q30435620-539B3135-C427-40B5-8D95-F30527338ACCQ30437086-9654B9FF-7AA0-4AB0-9840-D6DDE564B021Q30437433-A40F1AA4-9EAD-4844-B840-1B04E8CFE629Q30438821-E8453C19-5973-459D-BA29-9801EE457BC8Q30440768-58220064-99DF-40F5-8DF6-A0F69F2E2602Q30482911-84AC23DE-B6C6-4570-B9A7-250BA6312FDBQ33615249-1FD694A9-D126-46F7-A192-55F34C5DFD56Q34183010-821FC93D-0586-4A37-835B-9E6AD64BE508Q34847971-94CD07B6-72E2-4EC6-AA82-365366386E80Q35615129-32B919AF-7815-417C-A9BB-63DF62DCB617Q35624796-2BF85B1E-A2D9-4093-B78E-256EAB9BD30CQ35893688-011DFBAE-A622-48DF-9475-996CF83625A9Q36073028-6C944352-3D0B-4E96-ADDF-8374AF2BB1B0Q36183282-B89C2B7C-0A13-43BC-BC4E-42E57A32AE20Q36294009-32EBDA00-3DA0-49BA-B647-2BA8252F871AQ36497075-EE9D8848-1CC5-44AC-A631-37EE0B69F34DQ36508183-D314F428-6D9C-4E5B-AAA8-04326F7F0943Q36923670-64CD539D-0D88-4916-A897-5A3C1E3A72CFQ36993161-269D1DB6-7817-4DC1-8462-4DAF4E338DE9Q37419567-C96372D3-E1DB-496F-B675-C768F9DE9F31Q37497934-65626A85-0A31-449F-92C7-6F0068A7021FQ37876538-8E7AA4DA-E43E-4AB2-80DD-094494BEC907Q38367734-58976682-B016-4AB0-BC15-7888E2B78447Q39065203-2B369FA0-AFAC-4B05-9795-1856562B3A84Q39600549-102B1955-3E4D-4626-83E3-A0A7A3C62B28
P2860
A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A2A adenosine receptor activat ...... els of endotoxemia and sepsis.
@ast
A2A adenosine receptor activat ...... els of endotoxemia and sepsis.
@en
type
label
A2A adenosine receptor activat ...... els of endotoxemia and sepsis.
@ast
A2A adenosine receptor activat ...... els of endotoxemia and sepsis.
@en
prefLabel
A2A adenosine receptor activat ...... els of endotoxemia and sepsis.
@ast
A2A adenosine receptor activat ...... els of endotoxemia and sepsis.
@en
P2093
P356
P1476
A2A adenosine receptor activat ...... els of endotoxemia and sepsis.
@en
P2093
Gail W Sullivan
Guodong Fang
Joel Linden
W Michael Scheld
P304
P356
10.1086/386311
P407
P577
2004-04-28T00:00:00Z